Results 201 to 210 of about 20,422 (245)

LRP5 Variant Without Pseudoglioma in a Young Man With Fragility Fractures. [PDF]

JCEM Case Rep
Vaghasia N, Dutta A, Mithal A.
europepmc   +1 more source

Inhibitors of the Wnt pathway in osteoporosis: A review of mechanisms of action and potential as therapeutic targets. [PDF]

Biomol Biomed
Song J, Chang W, Wang Y, Gao P, Zhang J, Xiao Z, An F, Yan C.   +7 more
europepmc   +1 more source

Wnt/β-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy. [PDF]

Mol Cancer
Wu X, Que H, Li Q, Wei X.
europepmc   +1 more source

Inhibiting histone deacetylase 6 suppresses the proliferation of microvascular endothelial cells by epigenetically activating miR-375-3p, potentially contributing to bone loss during mechanical unloading. [PDF]

J Transl Med
Xu L, Zhang L, Li G, Zhang X, Sun Q, Hu Z, Cao X, Wang Y, Shi F, Zhang S.   +9 more
europepmc   +1 more source

Use of Teriparatide, Denosumab, and Romosozumab in a Postpartum Monogenic Osteoporosis With a <i>WNT1</i> Pathogenic Variation. [PDF]

JCEM Case Rep
Cavalcanti Matos T, Kistemann Gonçalves Dias M, Franco AS.   +2 more
europepmc   +1 more source

Embryonic cell origin defines functional role of Lrp5

Atherosclerosis, 2014
openaire   +3 more sources

MANF serves as a novel hepatocyte factor to promote liver regeneration after 2/3 partial hepatectomy via doubly targeting Wnt/β-catenin signaling. [PDF]

Cell Death Dis
Liang Y, Mei Q, He E, Ballar P, Wei C, Wang Y, Dong Y, Zhou J, Tao X, Qu W, Zhao M, Chhetri G, Wei L, Shao J, Shen Y, Liu J, Feng L, Shen Y.   +17 more
europepmc   +1 more source

A Review of the Relationship Between Insulin and Bone Health. [PDF]

Biomedicines
Ravindran S, Wong SK, Mohamad NV, Chin KY.   +3 more
europepmc   +1 more source

The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease. [PDF]

Clin Kidney J
Bi J, Guo W, Ji P, Li S, Wang P, Li Q, Xie Y.   +6 more
europepmc   +1 more source